Evangelia Steletou, Dimitra Metallinou, Alexandra Margeli, Theodoros Giannouchos, Athanasios Michos, Christina Kanaka-Gantenbein, . . . Tania Siahanidou. (2023). Serum YKL-40 as a Potential Biomarker for Sepsis in Term Neonates-A Pilot Study. MDPI AG.
Chicago Style (17th ed.) CitationEvangelia Steletou, Dimitra Metallinou, Alexandra Margeli, Theodoros Giannouchos, Athanasios Michos, Christina Kanaka-Gantenbein, Ioannis Papassotiriou, and Tania Siahanidou. Serum YKL-40 as a Potential Biomarker for Sepsis in Term Neonates-A Pilot Study. MDPI AG, 2023.
MLA (9th ed.) CitationEvangelia Steletou, et al. Serum YKL-40 as a Potential Biomarker for Sepsis in Term Neonates-A Pilot Study. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.